Jonathan C. Fox - 01 Apr 2025 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Role
Director
Signature
/s/ John R. Moore, Attorney-in-Fact for Fox Jonathan C
Issuer symbol
EWTX
Transactions as of
01 Apr 2025
Net transactions value
$0
Form type
4
Filing time
03 Apr 2025, 18:11:28 UTC
Previous filing
12 Jun 2024
Next filing
18 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EWTX Common Stock Award $0 +559 +5.1% $0.000000 11,416 01 Apr 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units granted and released to the reporting person on April 1, 2025, as a Quarterly Retainer Award pursuant to Section 2.4 of the Edgewise Therapeutics, Inc. Outside Director Compensation Policy, as amended.